Glycopeptide and daptomycin susceptibility and vancomycin heteroresistance of methicillin-resistant Staphylococcus aureus (MRSA) clinical isolates from a Greek university hospital

Int J Antimicrob Agents. 2011 Nov;38(5):451-2. doi: 10.1016/j.ijantimicag.2011.06.011. Epub 2011 Aug 15.

Authors

Theofano Panagea, Irene Galani, Maria Souli, Irene Karantani, Helen Giamarellou, George Petrikkos

PMID: 21840688
DOI: 10.1016/j.ijantimicag.2011.06.011

No abstract available

Publication types

Letter

MeSH terms

Anti-Bacterial Agents / pharmacology*
Daptomycin / pharmacology*
Drug Resistance, Multiple, Bacterial
Glycopeptides / pharmacology*
Greece / epidemiology
Hospitals, University
Humans
Methicillin-Resistant Staphylococcus aureus / drug effects*
Methicillin-Resistant Staphylococcus aureus / isolation & purification
Microbial Sensitivity Tests
Staphylococcal Infections / epidemiology
Staphylococcal Infections / microbiology*
Vancomycin Resistance*

Substances

Anti-Bacterial Agents
Glycopeptides
Daptomycin